No Data
No Data
Viking Therapeutics to Present Data From Phase 2b VOYAGE Study of VK2809 in Patients With Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting 2024
Is Viking Therapeutics a Buy on the Dip?
4 Reasons Why Buying Viking Therapeutics Stock Right Now Is a Smart Move
Peace Medical Acquired by Experienced Healthcare Professional, Ensuring Continuity and Growth
Got $5,000? Viking Therapeutics Stock Just Got a Big New Green Flag
Viking Therapeutics (VKTX) Stock Surges on Promising Treatment Pipeline
No Data
No Data